SOURCE: Brighton Markets

June 14, 2012 09:00 ET

Calendar of Events - Report Highlights Arena Pharmaceuticals, Inc. and VIVUS, Inc.

HONG KONG--(Marketwire - Jun 14, 2012) - Today, www.BrightonMarkets.com announced new reports highlighting Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) and VIVUS, Inc. (NASDAQ: VVUS). Gain market insight with full analysis and research downloads available at www.BrightonMarkets.com/index.php?coa=ARNA&cob=VVUS.

With markets in correction mode, investors are looking to quantify an accurate model, weighing positives and negatives of the months ahead. Upcoming negative pressures include China's slowdown, the European recession, the end of the Fed's Operation Twist stimulus program, continued geopolitical risks, election uncertainty, and potential 2013 budget bombshell of tax hikes and spending cuts. Meanwhile, positive offsets are driven by central banks (particularly China) cutting rather than hiking rates, deceleration in fuel and food prices, increase in consumer sentiment and resulting retail sales, signs of improvement in housing sales and new strength in auto production schedules.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Brighton Markets is releasing new coverage on Arena Pharmaceuticals, Inc. for its current position within the healthcare industry. Arena Pharmaceuticals, Inc. (Arena) is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors (GPCRs), in four therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. The full research report on Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) is available here: www.BrightonMarkets.com/index.php?coa=ARNA.

Brighton Markets has released research on VIVUS, Inc. for its changing role within the healthcare industry. VIVUS, Inc. is a biopharmaceutical company. The Company is engaged in the development and commercialization of therapeutic drugs for underserved markets, including obesity and related morbidities, such as sleep apnea and diabetes, and men's sexual health. The full research report on VIVUS, Inc. (NASDAQ: VVUS) is available here: www.BrightonMarkets.com/index.php?cob=VVUS.

About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.

Contact Information